News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
1h
InvestorsHub on MSNHims and Hers shares drop after revenue falls short amid GLP-1 scrutinyShares of Hims and Hers Health (NYSE:HIMS) slid 14% in premarket trading following the telehealth company’s announcement of ...
Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.
Eli Lilly ( LLY 0.73%) has been a terrific investment in recent years. Thanks to significant clinical progress and outstanding financial results, the company has become the largest healthcare player ...
A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results